Fueled by COVID drug manufacturing revenues, CDMO Jubilant HollisterStier invests in upgrades, expansion
Since the onset of the coronavirus pandemic, Jubilant HollisterStier has been busy churning out COVID-19 treatments and more recently vaccines. Now it’s turning those revenues from the increased business into an investment in the future. The Spokane, Washington-based CDMO revealed a $ 92 million expansion plan this week that includes a high-speed injectable fill line with… Read More »
